On Friday, Mirum Pharmaceuticals Inc (NASDAQ: MIRM) was 2.44% up from the session before settling in for the closing price of $45.83. A 52-week range for MIRM has been $23.14 – $48.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 111.13% over the past five years. When this article was written, the company’s average yearly earnings per share was at 58.79%. With a float of $38.32 million, this company’s outstanding shares have now reached $47.97 million.
Let’s look at the performance matrix of the company that is accounted for 264 employees. In terms of profitability, gross margin is 73.47%, operating margin of -30.44%, and the pretax margin is -31.09%.
Mirum Pharmaceuticals Inc (MIRM) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mirum Pharmaceuticals Inc stocks. The insider ownership of Mirum Pharmaceuticals Inc is 20.18%, while institutional ownership is 94.28%. The most recent insider transaction that took place on Jan 07 ’25, was worth 85,545. In this transaction PRESIDENT AND COO of this company sold 1,998 shares at a rate of $42.82, taking the stock ownership to the 27,015 shares. Before that another transaction happened on Jan 07 ’25, when Company’s CHIEF EXECUTIVE OFFICER sold 7,489 for $42.82, making the entire transaction worth $320,644. This insider now owns 119,359 shares in total.
Mirum Pharmaceuticals Inc (MIRM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 58.79% per share during the next fiscal year.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Trading Performance Indicators
You can see what Mirum Pharmaceuticals Inc (MIRM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.07, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -0.64 in one year’s time.
Technical Analysis of Mirum Pharmaceuticals Inc (MIRM)
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) saw its 5-day average volume 0.6 million, a positive change from its year-to-date volume of 0.49 million. As of the previous 9 days, the stock’s Stochastic %D was 86.87%. Additionally, its Average True Range was 1.73.
During the past 100 days, Mirum Pharmaceuticals Inc’s (MIRM) raw stochastic average was set at 83.87%, which indicates a significant decrease from 95.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.66% in the past 14 days, which was higher than the 38.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.23, while its 200-day Moving Average is $36.50. Nevertheless, the first resistance level for the watch stands at $47.57 in the near term. At $48.20, the stock is likely to face the second major resistance level. The third major resistance level sits at $49.35. If the price goes on to break the first support level at $45.79, it is likely to go to the next support level at $44.64. The third support level lies at $44.01 if the price breaches the second support level.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Key Stats
There are 48,005K outstanding shares of the company, which has a market capitalization of 2.25 billion. As of now, sales total 186,370 K while income totals -163,420 K. Its latest quarter income was 90,380 K while its last quarter net income were -14,240 K.
